免疫组织化学
病理
病态的
医学
肺癌
转移
化疗
鳞癌
癌
癌症
肺
细胞质
基底细胞
生物
内科学
生物化学
作者
Hiroyuki Yamada,Rin Yamada,Yoshihiro Komohara,Remi Mito,Kazuchika Nishitsuji,Hiromu Yano,Yukio Fujiwara,Koei Ikeda,Makoto Suzuki
出处
期刊:PubMed
日期:2024-03-04
卷期号:4 (2): 204-208
摘要
Immunohistochemistry for p53 was a well-established method for cancer diagnosis in pathology. Aberrant cytoplasmic p53 positivity reflects the accumulation of p53 aggregates, which has been shown to be associated with chemoresistance and to be a predictive marker of a worse clinical course in ovarian cancer.A 65-year-old Japanese man was diagnosed with lung cancer, and surgical resection was performed. Multiple metastasis were found 21 months post-surgery. The lesions were resistant to chemotherapy, and he succumbed to the disease 29 months post-surgery. The resected primary lesion was pathologically diagnosed as squamous cell carcinoma, with notable cytoplasmic p53 positivity indicated by immunohistochemistry.Notable aberrant cytoplasmic accumulation of p53 aggregate was observed in the cancer cells of this case. Chemotherapy was ineffective for the recurrent lesions, suggesting a role of p53 aggregates in chemoresistance. Pathological analysis of p53 via immunohistochemistry may be useful in predicting chemoresistance of lung squamous cell carcinoma.
科研通智能强力驱动
Strongly Powered by AbleSci AI